Pierre‐Louis Tharaux
Inserm(FR)Inserm(FR)Université Paris Cité(FR)Sorbonne Université(FR)Sorbonne Paris Cité(FR)Société Française de Médecine Vasculaire(FR)Paris Cardiovascular Research Center(FR)Institut du Fer à Moulin(FR)
Publications by Year
Research Areas
Renal Diseases and Glomerulopathies, Hemoglobinopathies and Related Disorders, Chronic Kidney Disease and Diabetes, COVID-19 Clinical Research Studies, Erythrocyte Function and Pathophysiology
Most-Cited Works
- → Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients(2020)3,146 cited
- → Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia(2020)773 cited
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II–infused mice(2010)408 cited
- → Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial(2021)294 cited
- → Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis(2015)289 cited